Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

Signature(s)

Amount
€ 15,000,000
Countries
Sector(s)
France : € 15,000,000
Services : € 15,000,000
Signature date(s)
21/07/2021 : € 7,500,000
21/07/2021 : € 7,500,000
Link to source
Data sheet

Summary sheet

Release date
31 October 2023
Status
Reference
Signed | 21/07/2021
20200330
Project name
Promoter - financial intermediary
SURGIVISIO (EGFF)
ECENTIAL ROBOTICS SAS
Proposed EIB finance (Approximate amount)
Total cost (Approximate amount)
EUR 15 million
EUR 40 million
Location
Sector(s)
  • Services - Professional, scientific and technical activities
Description
Objectives

The promoter is a French commercial stage innovative medical device company that designs and develops a robotic platform to assist surgeons in performing complex surgical procedures in a minimally invasive manner. The company successfully developed a fully integrated device for spine surgery, which consists in an imaging device and a navigation system, and is now focusing its efforts on adding a robotic arm to the platform and on leveraging its versatility to target new indications. The project includes: (i) the combination of the already marketed 3D imaging solution with a third party robotic arm; (ii) the regulatory approval (CE mark and FDA approval) of the unified 3D imaging and robotic system in spine surgery; (iii) the expansion of the range of applications of the robotic solution and (iv) the development of the next generation of the device.

By improving and commercialising the company's product, the project will foster the company's growth and create new jobs in the EU. Additionally, the project and all its research, development and innovation (R&D) activities, will contribute to the competitive search and generation of new knowledge across Europe in areas that are key to improve citizens' health.

Environmental aspects
Procurement

The activities to be financed are R&D in the medical technology sector, enabling the company to develop its robotic surgery products. Due to the project's characteristics, the project does not fall under Annex I or Annex II of the Environmental Impact Assessment (EIA) Directive 2014/52/EU amending Directive 2011/92/EU.

The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not covered by EU directives on procurement. However, the promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. The EIB's services verified details during the project due diligence.

Milestone
Under appraisal
Approved
Signed
18 December 2020
21 July 2021
Link to source
Summary sheet

Disclaimer

Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

Documents

Environmental and Social Data Sheet (ESDS) - SURGIVISIO (EGFF)
Publication Date
8 Nov 2023
Document language
Main Topic
Lending
Document Number
135712897
Document Focus
Environmental Information
Project Number
20200330
Sector(s)
Regions
Countries
Publicly available
Download now
scoreboard - EUROPEAN GROWTH FINANCE FACILITY
Publication Date
13 Sep 2019
Document Language
English
Main Topic
lending
Document Number
122912044
Document Focus
EFSI legal requirements
Document Type
Scoreboard
Project Number
20180667
Last update
19 Aug 2020
Sector(s)
Services
Countries
Bulgaria, Kenya, Ghana, Mexico, Philippines
Publicly available
Download now

News & Stories

Photogallery

General enquiries and comments

The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, the EIB can be contacted through its external offices.
Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

Media enquiries

Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

Complaints mechanism

Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

Zero tolerance against fraud and corruption

The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

Related publications